Cited by 930Pharmacological Receptor Mechanisms and EffectsNeuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments

Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders

Rupprecht, Rainer, Papadopoulos, Vassilios, Rammes, Gerhard, Baghai, Thomas C., Fan, Jinjiang, Akula, Nagaraju, Groyer, Ghislaine, Adams, David +1 more·2010·Nature Reviews Drug Discovery

Abstract

The translocator protein (18 kDa) (TSPO) is localized primarily in the outer mitochondrial membrane of steroid-synthesizing cells, including those in the central and peripheral nervous system. One of its main functions is the transport of the substrate cholesterol into mitochondria, a prerequisite for steroid synthesis. TSPO expression may constitute a biomarker of brain inflammation and reactive gliosis that could be monitored by using TSPO ligands as neuroimaging agents. Moreover, initial clinical trials have indicated that TSPO ligands might be valuable in the treatment of neurological and psychiatric disorders. This Review focuses on the biology and pathophysiology of TSPO and the potential of currently available TSPO ligands for the diagnosis and treatment of neurological and psychiatric disorders.

Integrity signals

Registry

Crossref · 10.1038/nrd3295

Cites

209 of 209 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • TSPO is a peripheral benzodiazepine receptor expressed on the outer mitochondrial layer of microglia, and is believed to be upregulated during microglial activation.

    “TSPO is a peripheral benzodiazepine receptor expressed on the outer mitochondrial layer of microglia, and is believed to be upregulated during microglial activation (Rupprecht et al, 2010).”

    From Microglia Priming with Aging and Stress (2017) · cites this paper as Rupprecht et al, 2010

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Rupprecht, R., Papadopoulos, V., Rammes, G., Baghai, T. C., Fan, J., Akula, N., Groyer, G., Adams, D., & Schumacher, M.
Affiliations
  • Ludwig-Maximilians-Universität München (DE)
  • Research Institute of the McGill University Health Centre (CA)
  • Max Planck Institute of Psychiatry (DE)
  • Georgetown University Medical Center (US)
  • Inserm (FR)
  • Assistance Publique – Hôpitaux de Paris (FR)
Venue
Nature Reviews Drug Discovery
Published
2010-12
Volume
9
Issue
12
Pages
971-988
ISSN
  • 1474-1776 (ISSN-L)
  • 1474-1784
OpenAlex
W2031648971
Cited by
930
References
209
Citations by year
2026: 20 · 2025: 38 · 2024: 74 · 2023: 54 · 2022: 57 · 2021: 78 · 2020: 81 · 2019: 53 · 2018: 86 · 2017: 69 · 2016: 65 · 2015: 79 · 2014: 56 · 2013: 50 · 2012: 41
FWCI
3.33
Type
journal article
Language
en
Open access
closed
Locations
  • Nature Reviews Drug Discovery (publishedVersion)
  • PubMed (publishedVersion)
  • Max Planck Institute for Plasma Physics (submittedVersion)
  • mediaTUM (Technical University of Munich) (submittedVersion)
Funders
  • Canadian Institutes of Health Research
  • National Institute of Environmental Health Sciences (R01ES007747, ES 07747)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pharmacological Receptor Mechanisms and Effects
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
translocator protein (TSPO), TSPO ligands, mitochondrial steroidogenesis, cholesterol transport, neuroinflammation, reactive gliosis, anxiety, neuropathic pain, amyotrophic lateral sclerosis, neurological disorders, mental illness, therapeutic target
MeSH terms
Animals, Mental Disorders, Disease Models, Animal, Humans, Ligands, Nervous System Diseases, Biomarkers, Drug Delivery Systems, Receptors, GABA

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review